CNCR Stock Range Cancer Therapeutics ETF (CNCR, $12.57) entered Downtrend as Momentum indicator drops below 0 level on Feb 20, 2025

GET DAILY SIGNALS

Get AI intraday signals

CNCR - Range Cancer Therapeutics ETF

Momentum signal

View

Odds of DOWN Trend

Price: $12.57

Daily change: -$0.23 (-1.8%)

Daily volume: 8K

Net Assets: $10M

CNCR saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for CNCR moved out of overbought territory on February 21, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 61 similar instances where the indicator exited the overbought zone. In of the 61 cases the stock moved lower. This puts the odds of a downward move at .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CNCR as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CNCR moved below its 50-day moving average on February 21, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CNCR broke above its upper Bollinger Band on February 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CNCR's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CNCR just turned positive on January 22, 2025. Looking at past instances where CNCR's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNCR advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 195 cases where CNCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .